Search research articles
Contact Us
Filters
Showing results (371-380 of 392) with videos related to
Page
of 40
Sort By:
International Journal of Cancer
|
July 13, 2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling
Jacqueline A Turner, Robert J Van Gulick, William A Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Cell
|
January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
JTO Clinical and Research Reports
|
February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Cancer Immunology Research
|
June 13, 2023
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer
Toshiyasu Suzuki, Anna Kilbey, Nuria Casa-Rodríguez, et al.
Nature Communications
|
January 5, 2021
A RAC-GEF network critical for early intestinal tumourigenesis
K A Pickering, K Gilroy, J W Cassidy, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2021
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
Marcelo V Negrao, Ferdinandos Skoulidis, Meagan Montesion, et al.
The Oncologist
|
October 13, 2019
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
Umut Disel, Russell Madison, Kumar Abhishek, et al.
Nature Communications
|
February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
Lingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 392) with videos related to
Sort By:
Page
of 40
International Journal of Cancer
|
July 13, 2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling
Jacqueline A Turner, Robert J Van Gulick, William A Robinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancer Cell
|
January 22, 2021
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M Gay, C Allison Stewart, Elizabeth M Park, et al.
Cancers
|
December 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer
Hui Li, Lingzhi Hong, Pedro Rocha, et al.
JTO Clinical and Research Reports
|
February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Cancer Immunology Research
|
June 13, 2023
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer
Toshiyasu Suzuki, Anna Kilbey, Nuria Casa-Rodríguez, et al.
Nature Communications
|
January 5, 2021
A RAC-GEF network critical for early intestinal tumourigenesis
K A Pickering, K Gilroy, J W Cassidy, et al.
Journal for Immunotherapy of Cancer
|
August 11, 2021
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
Marcelo V Negrao, Ferdinandos Skoulidis, Meagan Montesion, et al.
The Oncologist
|
October 13, 2019
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
Umut Disel, Russell Madison, Kumar Abhishek, et al.
Nature Communications
|
February 8, 2023
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
Lingzhi Hong, Muhammad Aminu, Shenduo Li, et al.
Page
of 40